Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
Investigative Ophthalmology & Visual Science
|
December 1, 1977
Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits
C B Camras, L Z Bito, K E Eakins
Drugs & Aging
|
December 22, 1999
Efficacy and adverse effects of medications used in the treatment of glaucoma
C B Camras, C B Toris, R R Tamesis
Journal of Glaucoma
|
March 9, 2000
Latanoprost-induced iris color darkening: a case report with long-term follow-up
C B Camras, D G Neely, E L Weiss
Ophthalmology
|
November 1, 1996
Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups
C B Camras, A Alm, P Watson, et al.
Current Opinion in Ophthalmology
|
June 10, 2000
Latanoprost and cystoid macular edema: is there a causal relation?
R A Schumer, C B Camras, A K Mandahl
Ophthalmology
|
September 1, 1993
Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes
C B Toris, C B Camras, M E Yablonski
Investigative Ophthalmology & Visual Science
|
March 1, 1983
Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes
L Z Bito, A Draga, J Blanco, et al.
The British Journal of Ophthalmology
|
June 5, 2008
Bimatoprost, the prodrug of a prostaglandin analogue
C B Camras, N A Sharif, M B Wax, et al.
Ophthalmology
|
July 1, 1991
Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients
P Y Lee, H Shao, C B Camras, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals
L Z Bito, C B Camras, G G Gum, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
Investigative Ophthalmology & Visual Science
|
December 1, 1977
Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits
C B Camras, L Z Bito, K E Eakins
Drugs & Aging
|
December 22, 1999
Efficacy and adverse effects of medications used in the treatment of glaucoma
C B Camras, C B Toris, R R Tamesis
Journal of Glaucoma
|
March 9, 2000
Latanoprost-induced iris color darkening: a case report with long-term follow-up
C B Camras, D G Neely, E L Weiss
Ophthalmology
|
November 1, 1996
Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups
C B Camras, A Alm, P Watson, et al.
Current Opinion in Ophthalmology
|
June 10, 2000
Latanoprost and cystoid macular edema: is there a causal relation?
R A Schumer, C B Camras, A K Mandahl
Ophthalmology
|
September 1, 1993
Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes
C B Toris, C B Camras, M E Yablonski
Investigative Ophthalmology & Visual Science
|
March 1, 1983
Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes
L Z Bito, A Draga, J Blanco, et al.
The British Journal of Ophthalmology
|
June 5, 2008
Bimatoprost, the prodrug of a prostaglandin analogue
C B Camras, N A Sharif, M B Wax, et al.
Ophthalmology
|
July 1, 1991
Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients
P Y Lee, H Shao, C B Camras, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals
L Z Bito, C B Camras, G G Gum, et al.
Page
of 6